Zydus Lifesciences has received a Warning Letter issued by the USFDA relating to its Injectables manufacturing facility at Jarod near Vadodara.
The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. The Warning Letter does not contain any data integrity related violations.
This site was inspected by USFDA from 15 April to 23 April 2024.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
